Beijing Suncadia Pharmaceuticals Co., Ltd
Clinical trials sponsored by Beijing Suncadia Pharmaceuticals Co., Ltd, explained in plain language.
-
New drug aims to tame dangerous blood fats in 360-Patient trial
Disease control Not yet recruitingThis study tests a new medicine called SHR-1918 to see if it safely lowers high triglycerides (a type of blood fat) in adults. About 360 people with moderately high triglycerides will receive either the drug or a placebo for up to 48 weeks. The main goal is to measure the change …
Phase: PHASE3 • Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd • Aim: Disease control
Last updated May 26, 2026 03:26 UTC
-
New heart failure drug enters first human safety trial
Disease control Not yet recruitingThis early-stage study tests a single injection of SHR-4658 in 48 healthy people and those with high blood pressure to see if it is safe and how the body processes it. The goal is to gather initial safety data for a potential heart failure treatment. Participants must be 18-55 an…
Phase: PHASE1 • Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd • Aim: Disease control
Last updated May 26, 2026 03:15 UTC
-
New hope for stubborn high cholesterol: experimental drug SHR-1918 enters trials
Disease control Not yet recruitingThis study tests a new drug called SHR-1918 for people with high cholesterol that remains high even after taking statins and another type of cholesterol-lowering drug (PCSK9 inhibitors). About 126 adults will receive either SHR-1918 or a placebo to see if it safely lowers their c…
Phase: PHASE2, PHASE3 • Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd • Aim: Disease control
Last updated May 26, 2026 03:15 UTC